ProBio De-Risks Cell & Gene Therapy with New Packaging Test

HOPEWELL, N.J., May 1, 2026 /PRNewswire/ -- To address the critical need for accelerated decision-making and de-risked progression from discovery to Chemistry, Manufacturing, and Controls (CMC) in cell and gene therapy programs, ProBio Inc. has launched its new Viral Vector Packaging Test....